dehydroepiandrosterone sulfate has been researched along with fludrocortisone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artman, HG; Digeorge, AM; Garibaldi, LR; Rezvani, I | 1 |
Abalain, JH; Bercovici, JP; Fiet, J; Floch, HH; Fournier, G; Gibault, L; Sonnet, E; Volant, A | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and fludrocortisone
Article | Year |
---|---|
Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Age Factors; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Fludrocortisone; Follow-Up Studies; Humans; Hydrocortisone; Male; Mixed Function Oxygenases | 1983 |
Testicular adrenal rest tumours in salt wasting congenital adrenal hyperplasia (in vivo and in vitro studies).
Topics: Adrenal Hyperplasia, Congenital; Adrenal Rest Tumor; Adrenocorticotropic Hormone; Adult; Dehydroepiandrosterone Sulfate; Dexamethasone; Diagnosis, Differential; Fludrocortisone; Follicle Stimulating Hormone; Follow-Up Studies; Glucocorticoids; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Hypogonadism; Inhibins; Leydig Cell Tumor; Luteinizing Hormone; Male; Prolactin; Renin; Steroid 21-Hydroxylase; Testicular Neoplasms; Treatment Refusal; Ultrasonography | 2005 |